PU-H71
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PU-H71, covering 2017-10-04 to 2017-10-04. Get the full timeline:
Most recent: Clinical Trial Update: PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment [Phase 1]